A key congressional oversight committee announced today that it was opening an investigation into the basis of a decision by the Pentagon's health plan to deny a type of medical treatment to troops with brain injuries.
Sen. Claire McCaskill, D-Mo., the chairman of the subcommittee on contracting oversight, said she wanted to examine a contract issued by Tricare, an insurance-style program used by soldiers and many veterans, to a private company to study cognitive rehabilitation therapy for traumatic brain injury. Such injuries are considered among the signature wounds of the wars in Afghanistan and Iraq.
The study, by Pennsylvania-based ECRI Institute, found insufficient or weak evidence to support the therapy. Often lengthy and expensive, cognitive rehabilitation programs are designed to rewire soldiers' brains to conduct basic life tasks, such as reading books, remembering information and following instructions.
ECRI's findings ran counter to several other studies, including ones sponsored by the Pentagon and the National Institutes of Health, which concluded that cognitive rehabilitation was beneficial.
When the ‘“department of government efficiency” was raging unchecked through the federal government in February 2025,...
The US defense secretary, Pete Hegseth, this week ordered an annual testosterone-deficiency screening for active-duty and...
